Rubin Marc

Rubin Marc is listed in filings as Director at Curis, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including 7 public disclosures. Recent filings connect the profile to Curis, Inc. (CRIS) and Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Jan 27, 2025 to Mar 23, 2026. Reported amounts are shown as $20.0K to $5.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.